Concepedia

Sofya Tsymbalov

ST

Statistics

Publications

7

Citations

338

H-Index

7

Active since

1993

Affiliations

Monsanto (United States)(Current)

Sofya Tsymbalov is an author at Monsanto (United States) specializing in medicinal chemistry, pharmacology, and medicine.

Publications per year

1993–2002

7

Publications

7

Synthesis and Biological Characterization of L-N<sup>6</sup>-(1-Iminoethyl)lysine 5-Tetrazole-amide, a Prodrug of a Selective iNOS Inhibitor

E. Ann Hallinan, Sofya Tsymbalov, Clifford R. Dorn et al. · Journal of Medicinal Chemistry · 2002 · 77 citations · Full text

, , +10

N-Substituted dibenzoxazepines as analgesic PGE2 antagonists

E. Ann Hallinan, Timothy J. Hagen, Robert K. Husa et al. · Journal of Medicinal Chemistry · 1993 · 72 citations

, , +12

Aminoacetyl Moiety as a Potential Surrogate for Diacylhydrazine Group of SC-51089, a Potent PGE<sub>2</sub> Antagonist, and Its Analogs

E. Ann Hallinan, Timothy J. Hagen, Sofya Tsymbalov et al. · Journal of Medicinal Chemistry · 1996 · 64 citations · Full text

, , +9

2,4-Disubstituted oxazoles and thiazoles as latent pharmacophores for diacylhydrazine of SC-51089, a potent PGE2 antagonist

E. Ann Hallinan, Timothy J. Hagen, Sofya Tsymbalov et al. · Bioorganic & Medicinal Chemistry · 2001 · 50 citations

, , +5

Enkephalin Analogs as Systemically Active Antinociceptive Agents: O- and N-Alkylated Derivatives of the Dipeptide Amide L-2,6-Dimethyltyrosyl-N-(3-phenylpropyl)-D-alaninamide

Barnett S. Pitzele, K. D. KUDLA, Sofya Tsymbalov et al. · Journal of Medicinal Chemistry · 1994 · 28 citations · Full text

, , +17

1–5 of 7